Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3524523

N=C(NCCCC1OCC2(CO1)COC(CCCNC(N)=NC(=O)c1nc(Cl)c(N)nc1N)OC2)NC(=O)c1nc(Cl)c(N)nc1N.O=C(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCNN1A P37088 16/20 0.36
ALDH1A1 P00352 6/20 0.36
KDM4E B2RXH2 5/20 0.36
GLA P06280 5/20 0.36
HPGD P15428 5/20 0.36
HSD17B10 Q99714 5/20 0.36
GAA P10253 3/20 0.36
CYP1A2 P05177 3/20 0.36
NPC1 O15118 2/20 0.36
CYP2D6 P10635 2/20 0.36
FTO Q9C0B1 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
MAPT P10636 1/20 0.36
NFKB1 P19838 1/20 0.36
THPO P40225 1/20 0.36
HIF1A Q16665 1/20 0.36
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
BLM P54132 2/20 0.35
GMNN O75496 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3524520 0.92 SCNN1A (0.36) SCNN1AALDH1A1KDM4EGLAHPGD
SCHEMBL13165420 0.87 PLAU (0.46) SCNN1AALDH1A1KDM4EGLAHPGD
SCHEMBL3524526 0.84 SCNN1A (0.38) SCNN1A
Trifluoroacetic Acid SCHEMBL3521532 0.82 SCNN1A (0.40) SCNN1AALDH1A1KDM4EGLAHPGD
Trifluoroacetic Acid SCHEMBL3524333 0.81 SCNN1A (0.40) SCNN1AALDH1A1KDM4EGLAHPGD
Trifluoroacetic Acid SCHEMBL3520461 0.81 SCNN1A (0.53) SCNN1AALDH1A1KDM4EGLAHPGD
Trifluoroacetic Acid SCHEMBL3527582 0.79 SCNN1A (0.43) SCNN1AALDH1A1KDM4EGLAHPGD
Trifluoroacetic Acid SCHEMBL3522161 0.76 SCNN1A (0.47) SCNN1AALDH1A1KDM4EGLAHPGD
Trifluoroacetic Acid SCHEMBL3522826 0.76 SCNN1A (0.40) SCNN1AALDH1A1KDM4EGLAHPGD
SCHEMBL3524557 0.75 SCNN1A (0.43) SCNN1AALDH1A1KDM4EGLAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7803804-B2 Substituted pyrazines for use in the treatment of inflammatory or allergic conditions NOVARTIS AG (CH) 2010-09-28 US disclosed
US-20080312217-A1 Organic Compounds NOVARTIS AG 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312217-A1 Organic Compounds TRPA1, TRPV1, CHRM1 SCNN1A 13/4885ALDH1A1 567/4885KDM4E 4641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.